Cotrimoxazole for community-acquired urinary tract infections leads to more adverse effects than fluoroquinolones
{{output}}
Background: For several years, we applied an internal guideline for community-acquired urinary tract infections (cUTI), targeting the reduction of fluoroquinolone use (FQ) and thereby favouring cotrimoxazole (CTM) prescription. O... ...
